Trexquant Investment’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Sell |
264,958
-25,101
| -9% | -$190K | 0.02% | 882 |
|
|
2025
Q1 | $1.6M | Buy |
290,059
+154,105
| +113% | +$851K | 0.02% | 939 |
|
|
2024
Q4 | $782K | Buy |
135,954
+67,040
| +97% | +$385K | 0.01% | 1176 |
|
|
2024
Q3 | $714K | Sell |
68,914
-10,009
| -13% | -$104K | 0.01% | 1160 |
|
|
2024
Q2 | $1.02M | Sell |
78,923
-16,716
| -17% | -$217K | 0.02% | 994 |
|
|
2024
Q1 | $1.67M | Sell |
95,639
-22,973
| -19% | -$401K | 0.03% | 714 |
|
|
2023
Q4 | $1.12M | Sell |
118,612
-13,949
| -11% | -$131K | 0.03% | 785 |
|
|
2023
Q3 | $1.48M | Buy |
+132,561
| New | +$1.48M | 0.04% | 597 |
|
|
2022
Q4 | – | Sell |
-4,882
| Closed | -$253K | – | 1460 |
|
|
2022
Q3 | $253K | Sell |
4,882
-1,370
| -22% | -$71K | 0.01% | 1099 |
|
|
2022
Q2 | $296K | Buy |
+6,252
| New | +$296K | 0.01% | 1126 |
|
|
2021
Q3 | – | Sell |
-7,958
| Closed | -$350K | – | 1228 |
|
|
2021
Q2 | $350K | Buy |
+7,958
| New | +$350K | 0.03% | 636 |
|
|
2021
Q1 | – | Sell |
-7,124
| Closed | -$300K | – | 1200 |
|
|
2020
Q4 | $300K | Sell |
7,124
-8,514
| -54% | -$359K | 0.03% | 689 |
|
|
2020
Q3 | $716K | Buy |
15,638
+7,802
| +100% | +$357K | 0.05% | 536 |
|
|
2020
Q2 | $393K | Buy |
+7,836
| New | +$393K | 0.03% | 767 |
|
|
2019
Q3 | – | Sell |
-3,824
| Closed | -$323K | – | 925 |
|
|
2019
Q2 | $323K | Sell |
3,824
-11,180
| -75% | -$944K | 0.03% | 580 |
|
|
2019
Q1 | $1.43M | Buy |
+15,004
| New | +$1.43M | 0.1% | 287 |
|
|
2018
Q3 | – | Sell |
-5,266
| Closed | -$610K | – | 1005 |
|
|
2018
Q2 | $610K | Buy |
+5,266
| New | +$610K | 0.04% | 486 |
|
|
2018
Q1 | – | Sell |
-8,620
| Closed | -$506K | – | 1154 |
|
|
2017
Q4 | $506K | Buy |
+8,620
| New | +$506K | 0.06% | 509 |
|